Publication
Article
BioPharm International
Designing and Operating Flexible, High-Containment Vaccine Manufacturing
Author(s):
A new facility type integrates next-generation mobile cleanroom systems.
Facilities for advanced therapies should be configurable to flexibly segregate production for late-stage and commercial multiproduct operation. Efficient design of a flexible and high-containment vaccine manufacturing facility that can meet all the challenges presented by the market requires a design philosophy that includes all the key control concepts: air, people, equipment, product, and liquid and solid waste. This article discusses best practices for such control and describes the use of modular, mobile cleanrooms.
Download
Pharmaceutical Technology and BioPharm International’s 2017 Vaccine Development and Manufacturing 2017eBook.
Article Details
Pharmaceutical Technology and BioPharm International
eBook: Vaccine Development and Manufacturing 2017
November 2017
Pages: 26–30
Citation
When referring to this article, please cite it as T. Page, "Designing and Operating Flexible, High-Containment Vaccine Manufacturing," Pharmaceutical Technology and BioPharm International Vaccine Development and Manufacturing 2017 eBook (November 2017).
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
